Zhang Rui-Yan, Zhu Shi-Jie, Xue Peng, He Sheng-Qi
Department of Oncology, Wangjing Hospital, China Academy of Chinese Medicine Sciences, Beijing 100102, China.
World J Clin Cases. 2022 May 16;10(14):4676-4683. doi: 10.12998/wjcc.v10.i14.4676.
Esophageal cancer is a common cause of cancer-related death worldwide. Cutaneous metastasis of esophageal squamous cell carcinoma is rare, particularly in diffuse skin metastasis.
In this case report, we describe an 82-year-old male who was diagnosed with esophageal squamous cell carcinoma. The tumor was staged as T4N3M1 (Stage IVB). The pathological findings revealed poorly differentiated squamous cell carcinoma of the esophagus. Four months after diagnosis, the patient began chemotherapy, and symptoms were relieved after four cycles of chemotherapy. After that, the patient returned home without a systematic physical examination. One year after diagnosis, the patient realized that the skin of the abdominal wall was hard and rough without pain, and the color became darker than normal skin. Thirteen months after diagnosis, a biopsy of the patient's abdominal lesion revealed that the skin metastasis was derived from the esophagus. Then the patient received two cycles of apatinib combined with docetaxel, but the abdominal lesion worsened. Two cycles of nivolumab were administered, but the patient eventually died of multiple organ failure.
This report highlights cutaneous metastasis as a late and untreatable metastasis of esophageal cancer.
食管癌是全球癌症相关死亡的常见原因。食管鳞状细胞癌的皮肤转移罕见,尤其是弥漫性皮肤转移。
在本病例报告中,我们描述了一名82岁男性,他被诊断为食管鳞状细胞癌。肿瘤分期为T4N3M1(IVB期)。病理结果显示为食管低分化鳞状细胞癌。诊断后四个月,患者开始化疗,四个周期化疗后症状缓解。此后,患者未进行系统体格检查便回家了。诊断后一年,患者发现腹壁皮肤变硬、粗糙但无痛,且颜色比正常皮肤更深。诊断后13个月,对患者腹部病变进行活检显示皮肤转移源自食管。随后患者接受了两个周期的阿帕替尼联合多西他赛治疗,但腹部病变恶化。给予两个周期的纳武单抗治疗,但患者最终死于多器官功能衰竭。
本报告强调皮肤转移是食管癌晚期且无法治疗的转移方式。